Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

European Research Council grant · Running

BESPOKE BESPOKE – Bacterial Enzyme and Surface Polymer Exploration Kit

Coordinator
Medizinische Hochschule Hannover, Germany
Runs
1 May 2026 to 30 April 2031
Status
Running
EU funding
€2.0m
Total cost
€2.0m
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101229953

What the project is doing

In the project's own words, from its summary on CORDIS.

Antimicrobial resistance (AMR) is a major health challenge and predicted to be associated with 8-10 million deaths per year by 2050. Gram-positive pathogens from the genus Enteroccocus and Gram-negative extra-intestinal pathogenic Escherichia coli (ExPEC) are critical multidrug-resistant bacteria for which effective therapies are urgently needed. Both pathogens cause various types of infections, can survive in different biological niches, and can even be a beneficial part of the human gut microbiome.

Glycoconjugate vaccines have proven highly effective for the prevention of bacterial infections. However, their development for Enterococcus spp. and ExPEC infections is hindered by the lack of knowledge about (i) the diversity, structure and identity of cell surface polymers expressed on Enterococcus spp. and ExPEC, (ii) how these polymers determine the biological niche a strain inhibits or the type of infection it causes, and (iii) what polymers to target to distinguish between beneficial and harmful strains.

In BESPOKE we will explore and exploit bacterial cell surface polymers of Enterococcus spp. and ExPEC in an unprecedented manner. Using a bottom-up approach - from genome, to enzyme, to polymer – we aim to synthesize and structurally characterize the cell surface polymers in a pathogen-free way to elucidate the structural diversity that is presented to the human immune system during various types of infection. In addition, we will explore and biochemically investigate the as yet poorly understood cell wall polymer biosynthesis machineries on genome and enzyme level to make them available as marker for the surveillance of local epidemiology and as synthesis tools for biotechnological exploitation.

Finally, we aim to build a highly versatile mix-and-match platform for the synthesis of glycoconjugate vaccines against bacterial infections that will help fight AMR and allow to respond quickly to local changes in epidemiology.

Topics

Who is involved

OrganisationCityCountryRole
Medizinische Hochschule HannoverHannoverGermanyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI